Introduction
Biomaterial related infections are difficult to eradicate because the biofilm mode of growth protects the infecting organisms against environmental attacks. 11 In the biofilm mode of growth, bacteria are embedded in an exopolymeric matrix, which contributes to effectively protecting the organisms against antimicrobial therapy, although the exact mechanisms of increased antibiotic resistance of bacteria in biofilms are not known. Current hypotheses include a slow or incomplete penetration of the antibiotic into the biofilm, an altered chemical microenvironment within the biofilm, or the formation of bacterial sub-populations in a resistant phenotypic state. 31 Biomaterial related infections cause failure of total hip and knee arthroplasties in 1% to 5% of the almost half a million surgeries annually performed worldwide. 2, 19 Acrylic bone cement is widely used to fixate these joint prostheses, and it is assumed that loading bone cement with an antibiotic may decrease the infection rate by local release of antibiotic. 21, 34 Advantages of these local drug releasing systems are that a high concentration of the drug can be achieved locally and possible side-effects of high systemic drug concentrations can be limited or avoided. Despite high initial release rates, antibiotic release rates over time are low and about 85% of the antibiotic is retained in currently applied bone cements. 17, 23, 35 It was hypothesized that the antibiotic release pattern of antibiotic-loaded bone cement is partially a surface phenomenon whereas the total amount of antibiotic released depends on bulk porosity. 3 Ultrasound has been used in various medical applications, including medical diagnostic imaging and physiotherapeutic treatment. 12 Recently, ultrasonically activated drug delivery in chemotherapy was tested in vivo. 20 More important for the present study, ultrasound is also effective in enhancing the efficacy of antibiotics, defined as the "bio-acoustic effect", 24 whereas ultrasound itself proved, under certain conditions, not to influence bacterial viability in biofilms. 24, 28 Exposure of an Escherichia coli biofilm on polyethylene to low-frequency ultrasound for 24
and 48 h in a 1:3 duty cycle with a peak acoustic intensity of 500 mW/cm 2 and a temporal mean acoustic intensity of 167 mW/cm 2 yielded a decreased bacterial viability by gentamicin in rabbits. 9, 29 Ultrasound increases the transport of gentamicin across and within the biofilm, as it presumably also increases the transport of oxygen and other small molecules which may increase the metabolic state and render cells more susceptible to the antibiotic. 7 Ideally, to prevent biofilm infection of implants, a high concentration of antibiotic should be achieved around an implant immediately after surgery to eradicate planktonic bacteria, present as an inevitable result of contamination during surgery.
The bio-acoustic effect could optimize infection prevention. For example, antibioticloaded bone cement has been modelled as consisting of an insoluble matrix, with pores and channels in the bulk through which gentamicin can elute through diffusion, 1, 10, 17 which elution could possibly be accelerated by ultrasound. 13 Therefore, the aim of this study is to investigate whether pulsed ultrasound in combination with gentamicin yields a decreased viability of bacteria in biofilms on unloaded and gentamicin-loaded acrylic bone cement. To this end, we compared the survival of bacteria in a biofilm on implanted bone cement disks with and without application of ultrasound in a rabbit model.
Materials and methods

Preparation of bone cement disks and biofilm formation
Palacos, bone cement without gentamicin, and Palacos G, bone cement containing 0.84 w/w% gentamicin base were used. These two commercially available acrylic bone cements (Schering-Plough, Maarssen, The Netherlands) were prepared by mixing the powdered methylmethacrylate with the liquid monomer in a bowl with a spatula. Manual mixing was done according to the manufacturer's instructions and resulted in liquid cement. The liquid cement was poured into a polytetrafluoroethylene mould and immediately pressed between two glass plates for 25 min. After hardening, the circular cement disks with a total surface area of 8.17 cm 2 were pulled out of the mould and stored under dark, sterile conditions at room temperature.
In order to mimic aged gentamicin-loaded bone cement, as after several years of implantation, Palacos G was also studied after the initial release of gentamicin. To this end, 20 samples of Palacos G were immersed in 1 l of phosphate-buffered saline (PBS: solution of 10 mM potassium phosphate and 150 mM NaCl with a pH of 7.0) in a low rate shaking system (Gyrotory® water bath shaker Model G 76, New Brunswick Scientific Co. Inc., USA) at room temperature for 14 days. Thus prepared samples will be referred to as "post-elution Palacos G" (PePaG).
E. coli ATCC 10798 was used, as described before, Lake City, UT, USA) was used to boost the voltage going to the ultrasound transducer (EDO Acoustics, Salt Lake City, UT, USA). To calibrate an acoustic intensity of 500 mW/cm 2 during the pulse, the output signal was measured in advance by a calibrated hydrophone (Bruel and Kjaer, Naerum, Denmark).
The transducer was fixed on a rabbit using an acoustically conductive gel adhesive Fourty-eight hours after initiation of the ultrasound treatment, the rabbits were euthanized with a 1 ml intravenous injection of a solution composed of 26% sodium pentobarbital and 7.8% isopropyl alcohol (Sleepaway, Ft. Dodge, IA, USA).
Thereafter the implanted disks with biofilm were removed from the subcutaneous fascia and fibrous capsule. The tabs, used to suture the disks subcutaneously, were cut from the disks and each circular disk (8.17 cm 2 ) was placed in a separate test tube, filled with 10 ml of 0.05% trypsin solution. A skin sample of the location of the transducer was removed from each rabbit and the kidneys from one rabbit in each experimental group were removed for histopathological examination.
Biofilm evaluation
For biofilm evaluation, the bone cement disks were sonicated in the test tubes in a Sonicor SC-100 sonicating bath (Sonicor Instrument Co., Copiaque, NY, USA) at 70 kHz for 10 s at 37°C to remove adherent bacteria; this was previously shown not to decrease bacterial viability. 7 Bacteria removed from the disk were quantified by serial dilution in sterile physiological saline solution and membrane filtration using 0.45 μm cellulose acetate filters (Gelman Sciences, Ann Arbor, MI, USA).
The first tube in each dilution series contained 0.1% polysorbate 80 (Tween 80) to reduce bacterial clumping. After the filtration, the membranes were placed on NA plates and incubated at 37°C for 48 h. CFU's were counted and CFU/cm 2 on each disk were computed. A decrease in viability of bacteria in biofilm was defined as the decrease in mean bacterial counts when ultrasound was applied.
Statistical analysis
The Statistical Package for Social Sciences (SPSS 10.0 for Windows, SPSS Inc., Chicago, IL, USA) was used. The two-tailed Wilcoxon signed rank test for paired samples was performed for statistical analysis in all combined experimental groups. The experimental groups involving the use of gentamicin were combined for statistical analysis, which was allowed because mean values, standard deviations, and correlations were comparable without significant linear regressions between these groups.
Results
The cement disks contained on average in all groups 2.3 x 10 9 CFU/cm 2 of biofilm bacteria before implantation. After 72 h of implantation, the negative controls (US off) all showed (see Table 1 ) a decrease in bacterial counts; both systemically released gentamicin (Pa) and locally released gentamicin (PaG and PePaG) reduced the CFU. Of these negative controls, PaG showed the highest reduction in CFU. Analysis after necropsy showed that within 48 h a well-organized, subcutaneous capsule of fibrin, heterophils and bacteria had formed around the implanted disks on both sides. Edema, congestion and inflammation were prominent, surrounding the capsule. Capsules around cement disks not subjected to ultrasound showed more signs of inflammation in all experimental groups: capsule formation was more extensive; capsules were larger and were mostly filled with larger volumes of pustular fluid. In general, these qualitative findings were in accordance with the reduced numbers of viable bacteria on cement disks treated with ultrasound in the experimental groups. No signs of specific skin degradation or necrosis were observed due to ultrasound in either group. Histopathological studies of the kidneys from one rabbit in each experimental group showed no abnormalities, such as signs of nephrotoxicity, and none of the blood samples showed bacteraemia.
Discussion
No effective non-invasive technique is available to prevent or treat biofilm infections associated with medical implants. This is important as most of the time an infection can only be successfully treated by a complete surgical removal of the implant. Therefore attempts have been undertaken to develop techniques to treat biofilm infections on medical implants. These include electric and ultrasonic enhancement of antibiotics, coating of biomaterials with antibiotic, and embedding antibiotics in biomaterials, such as in acrylic bone cement. 5, 6, 16, 30 Numerous studies demonstrated an effect of ultrasound in combination with an antibiotic on bacterial populations, 8, 15, 22, 25, 36 but none of these studies involve ultrasound effects in combination with the controlled release of antibiotics from antibiotic-loaded bone cements.
This study showed that ultrasound in combination with gentamicin yielded a tendency towards a decreased viability of bacteria in biofilms growing on acrylic bone cements in all groups. Ultrasound decreased the percentage bacterial viability (see Table 1 ) and was largest for plain bone cement (Pa) in combination with the use of systemic antibiotics, but decreased bacterial viability (see also The present experimental set-up might have underestimated (ultrasound) effects on bacterial viability for the group of PaG. First, the elution characteristics of antibiotic-loaded bone cements show that the initial release burst of antibiotics from bone cement occurs in the first 6-10 h. 4, 27 In the model used in this paper, a biofilm was seeded on bone cement in liquid media for 24 h. Therefore the gentamicin release for the samples in the PaG group was lower than could be expected from newly implanted PaG. Nevertheless in the PaG group, the reduction observed in the negative controls (US off) were highest, indicating that local release of gentamicin still occurs and can be considered to be more effective in decreasing bacterial viability in biofilm on bone cement than systemic administration (Pa group) of gentamicin. Secondly, because a larger part of the original biofilm is likely to be already eradicated by the higher local gentamicin concentration, there is less biofilm to decrease viability compared to the groups of Pa and PePaG, although remaining biofilm is known to be harder to eradicate. Nevertheless, the percentage decreased viability by ultrasound remains on a level in which ultrasound reduces remaining biofilm by more than 50%. Thirdly, after implantation, gentamicin that is released from PaG and PePaG spreads into a large volume of subcutaneous area, which is much larger than the small prosthesis-related gap 14 In conclusion, application of ultrasound resulted in a decreased (>50%) bacterial viability in biofilms in combination with systemic gentamicin and with gentamicin released from antibiotic-loaded bone cement in comparison with a negative control.
These results suggest that application of ultrasound during the early postoperative days combined with usage of antibiotic-loaded bone cement or systemic antibiotics may contribute to the prevention of implant infection in future clinical practice.
